Mito-LND;Mito-Loidamine;Mito-Lonidamine,mTOR,Autophagy,Mitochondrial Metabolism,p70S6K,oxidative,MitoLND,Inhibitor,inhibit,mitochondria,Mito LND,anti-invasive,anti-cancer,Reactive Oxygen Species,phosphorylation,AKT,Mito-LND;(10-(1-(2,4-Dichlorobenzyl)-1H-indazole-3-carboxamido)decyl)triphenylphosphonium bromide;Mito-LND, 10 mM in DMSO
Mito-LND is an orally active, mitochondria-targeted oxidative phosphorylation (OXPHOS) inhibitor; it inhibits mitochondrial bioenergetics, stimulates reactive oxygen species (ROS) formation, and induces autophagic cell death in lung cancer cells.